1
|
Figueirêdo PDMS, Sampaio Filho JC, Sodré ADJS, de Castro Júnior JR, Gonçalves IS, Blasques RV, S Correa R, Lima BAV, Dos Anjos Marques L, Coutinho DF, de Azevedo Dos Santos APS, Luz TRSA, de Miranda RDCM, Dos Santos JRA, Doriguetto AC, Pividori MI, Hörner M, Villis PCM. Assessment of the biological potential of diaryltriazene-derived triazene compounds. Sci Rep 2021; 11:2541. [PMID: 33510223 PMCID: PMC7844262 DOI: 10.1038/s41598-021-81823-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Accepted: 01/11/2021] [Indexed: 01/21/2023] Open
Abstract
In the present study, novel, 1,3-diaryltriazene-derived triazene compounds were synthesized and tested. Triazenes are versatile and belong to a group of alkylating agents with interesting physicochemical properties and proven biological activities. This study describes the synthesis, molecular and crystalline structure, biological activity evaluation, and antifungal and antimicrobial potentials of 1,3-bis(X-methoxy-Y-nitrophenyl)triazenes [X = 2 and 5; Y = 4 and 5]. The antimicrobial and antifungal activities of the compounds were tested by evaluating the sensitivity of bacteria (American Type Culture Collection, ATCC) and clinical isolates to their solutions using standardized microbiological assays, cytotoxicity evaluation, and ecotoxicity tests. The antimicrobial potentials of triazenes were determined according to their minimum inhibitory concentrations (MICs); these compounds were active against gram-positive and gram-negative bacteria, with low MIC values. The most surprising result was obtained for T3 having the effective MIC of 9.937 µg/mL and antifungal activity against Candida albicans ATCC 90028, C. parapsilosis ATCC 22019, and C. tropicallis IC. To the best of our knowledge, this study is the first to report promising activities of triazene compounds against yeast and filamentous fungi. The results showed the potential utility of triazenes as agents affecting selected resistant bacterial and fungal strains.
Collapse
Affiliation(s)
| | - José Costa Sampaio Filho
- Electrochemistry and Biotechnology Laboratory (EBL), University of CEUMA (UNICEUMA), São Luís, MA, 65.065-470, Brazil
| | | | | | - Ingrid Santos Gonçalves
- Electrochemistry and Biotechnology Laboratory (EBL), University of CEUMA (UNICEUMA), São Luís, MA, 65.065-470, Brazil
| | - Rodrigo Vieira Blasques
- Department of Nature Sciences, Mathematics, and Education, Federal University of São Carlos, Araras, SP, 13.600-970, Brazil
| | - Rodrigo S Correa
- Instituto de Ciências Exatas e Biológicas (ICEB), Federal University of Ouro Preto (UFOP), Ouro Preto, MG, 35.400-000, Brazil
| | | | - Larissa Dos Anjos Marques
- Laboratório de Microbiologia Clínica, Federal University of Maranhão (UFMA), São Luís, MA, 65.080-040, Brazil
| | - Denise Fernandes Coutinho
- Laboratório de Farmacognosia, Federal University of Maranhão (UFMA), São Luís, MA, 65.080-040, Brazil
| | | | | | | | | | | | - María Isabel Pividori
- Grup de Sensors i Biosensors, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain
| | - Manfredo Hörner
- Department of Chemistry, Federal University of Santa Maria (UFSM), Santa Maria, RS, 97.110-900, Brazil
| | - Paulo Cesar Mendes Villis
- Electrochemistry and Biotechnology Laboratory (EBL), University of CEUMA (UNICEUMA), São Luís, MA, 65.065-470, Brazil.
| |
Collapse
|
2
|
Francisco AP, Mendes E, Santos AR, Perry MJ. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules. Curr Pharm Des 2020; 25:1623-1642. [PMID: 31244412 DOI: 10.2174/1381612825666190617155749] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Accepted: 05/20/2019] [Indexed: 11/22/2022]
Abstract
Triazenes are a very useful and diverse class of compounds that have been studied for their potential in the treatment of many tumors including brain tumor, leukemia and melanoma. Novel compounds of this class continue to be developed as either anticancer compounds or even with other therapeutic applications. This review focused on several types of triazenes from the simplest ones like 1,3-dialkyl-3-acyltriazenes to the more complex ones like combi-triazenes with an emphasis on how triazenes have been developed as effective antitumor agents.
Collapse
Affiliation(s)
- Ana P Francisco
- iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Eduarda Mendes
- iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Ana R Santos
- iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| | - Maria J Perry
- iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
| |
Collapse
|